US Patent Issued to Vanda Pharmaceuticals on March 31 for "Cancer treatment" (Maryland Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,162, issued on March 31, was assigned to Vanda Pharmaceuticals Inc. (Washington).

"Cancer treatment" was invented by Mihael H. Polymeropoulos (Potomac, Md.), Louis William Licamele (Potomac, Md.) and Christian Lavedan (Potomac, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates generally to the treatment of cancer. One embodiment of the invention provides a method of treating cancer in an individual, the method comprising: administering to the individual an effective amount of trichostatin A (TSA)."

The patent was filed on April 25, 2023, under Application No. 18/306,601.

*For further information, including images, charts an...